Tactile Systems Technology(US:TCMD) Globenewswireยท2025-08-04 20:05Core Insights - Tactile Systems Technology, Inc. reported strong financial performance in Q2 2025, with total revenue growth of nearly 8% year-over-year, reaching $78.9 million, exceeding previous expectations [3][4] - The company is focused on three strategic priorities for 2025: improving access to care, expanding treatment options for lymphedema patients, and enhancing lifetime patient value [3] - The company expects to benefit from its strategic investments and initiatives starting in 2026 [3] Financial Performance - Total revenue for Q2 2025 increased by $5.7 million, or 7.8%, compared to Q2 2024, driven by a 52% increase in airway clearance product sales and a 2% increase in lymphedema product sales [4] - Gross profit for Q2 2025 rose by $4.7 million, or 9%, to $58.8 million, with a gross margin of 75% compared to 74% in Q2 2024 [5] - Operating expenses increased by $6.5 million, or 13%, to $54.7 million, primarily due to planned strategic investments [6] Income and Earnings - Operating income for Q2 2025 was $4.1 million, down from $5.8 million in Q2 2024 [6] - Net income for Q2 2025 was $3.2 million, or $0.14 per diluted share, compared to $4.3 million, or $0.18 per diluted share, in Q2 2024 [7][8] - Adjusted EBITDA for Q2 2025 was $7.7 million, down from $9.1 million in Q2 2024 [9] Year-to-Date Performance - For the first six months of 2025, total revenue increased by $5.9 million, or 4%, to $140.2 million compared to the same period in 2024 [10] - Net income for the first half of 2025 was $0.2 million, or $0.01 per diluted share, compared to $2.1 million, or $0.09 per diluted share, in the first half of 2024 [11] Balance Sheet and Cash Flow - As of June 30, 2025, the company had $81.5 million in cash and cash equivalents, down from $94.4 million at the end of 2024 [12] - The company repurchased $26.6 million of its stock during the first half of 2025 to complete its share repurchase program [12] - Cash flows from operating activities for the first half of 2025 were $15.2 million, compared to $14.1 million in the same period of 2024 [31] Financial Outlook - The company updated its 2025 financial outlook, now expecting total revenue in the range of $310 million to $315 million, representing growth of approximately 6% to 8% year-over-year [14] - Adjusted EBITDA for 2025 is expected to be in the range of $33 million to $35 million, compared to $37.1 million in 2024 [15]